Showing 1 - 3 results of 3 for search 'Namita Sood', query time: 0.03s Refine Results
  1. 1
    Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study

    Riociguat improves health-related quality of life for patients with pulmonary arterial hypertension: results from the phase 4 MOTION study by Namita Sood, Alvaro Aranda, David Platt, Anneliese LaRose, Frank Kleinjung, Gerald O’Brien

    Published 2019-02-01
    Get full text
    Article
  2. 2
    Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies)

    Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies) by Hossein-Ardeschir Ghofrani, Ekkehard Grünig, Pavel Jansa, David Langleben, Stephan Rosenkranz, Ioana R. Preston, Franck Rahaghi, Namita Sood, Dennis Busse, Christian Meier, Marc Humbert

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat

    Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat by Franck F. Rahaghi, Vijay P. Balasubramanian, Robert C. Bourge, Charles D. Burger, Murali M. Chakinala, Michael S. Eggert, Jean M. Elwing, Jeremy Feldman, Christopher King, James R. Klinger, Stephen C. Mathai, John Wesley McConnell, Harold I. Palevsky, Ricardo Restrepo‐Jaramillo, Zeenat Safdar, Jeffrey S. Sager, Namita Sood, Roxana Sulica, R. James White, Nicholas S. Hill

    Published 2022-04-01
    Get full text
    Article

Search Tools: